Advertisement

Lifestyle Medicine and HIV-Infected Patients

  • Vani Gandhi
  • Tiffany Jung
  • Jin S. SuhEmail author
Chapter

Abstract

More than 30 years have passed since HIV/AIDS first emerged as an epidemic. Through significant developments in treatment options, people are living longer with HIV than ever before, with life expectancy approaching those in the general population. However, antiretroviral therapies do not offer a cure and many are associated with significant side effects. An integrative approach utilizing lifestyle modifications can lead to numerous benefits, including improvement of immune function, better tolerability of symptoms, and most importantly, increased quality of life. Through the incorporation of HIV medications with nutrition, exercise, and stress-reduction strategies, patients can be empowered to achieve greater health and longevity.

Keywords

HIV Lifestyle Nutrition Exercise Stress reduction 

Abbreviations

ART

Antiretroviral therapy

ACSM

The American College of Sports Medicine

BMI

Body Mass Index

CVD

Cardiovascular disease

FDA

Food and drug administration

HAART

Highly active antiretroviral therapy

HPA

Hypothalamic-pituitary-adrenal

MetS

Metabolic syndrome

NNRTIs

Non-nucleoside reverse transcriptase inhibitors

NRTIs

Nucleoside/nucleotide reverse transcriptase inhibitors

NFHL

Nutrition for healthy living

SAM

Sympathetic-adrenomedullary

SNAP EBT

Supplemental nutrition assistance program electronic benefits transfer

STDs

Sexually transmitted diseases

T2D

Type-2 diabetes

References

  1. 1.
    Suh JS, Gandhi V. Management of HIV-infected patients. In: Rakel R, Bope E, editors. Conn’s current therapy. 58th ed. Philadelphia: W.B. Saunders; 2006.Google Scholar
  2. 2.
    Suh JS, Sepkowitz KA. Treatment of HIV related opportunistic infections. In: Reese RE, Betts RF, editors. A practical approach to infectious diseases. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2003.Google Scholar
  3. 3.
    Hone-Blanchet A, Fecteau S. Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies. Neuropharmacology. 2014;85:81–90.Google Scholar
  4. 4.
    Jarrett OD, Wanke CA, Ruthazer R, et al. Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus. AIDS Patient Care STDS. 2013;27(5):266–71.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, Midwestern, US outpatient population. Clin Infect Dis. 2007;44:726–34.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Giugliano D, Esposito K. Mediterranean diet and metabolic diseases. Curr Opin Lipidol. 2008;19:63–8.PubMedGoogle Scholar
  7. 7.
    Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA. 2004;292:1433–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Fitch KV, Anderson EJ, Hubbard JL, et al. Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome. AIDS. 2006;20:1843–50.CrossRefPubMedGoogle Scholar
  9. 9.
    Botros D, Somarriba G, Neri D, Miller TL. Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals. Curr HIV/AIDS Rep. 2012;9(4):351–63.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Breen C, Ryan M, Gibney MJ, et al. Glycemic, insulinemic, and appetite responses of patients with type-2 diabetes to commonly consumed breads. Diabetes Educ. 2013;39(3):376–86.CrossRefPubMedGoogle Scholar
  11. 11.
    Conteas CN, Panossian AM, Tran TT, Singh HM. Treatment of HIV-associated diarrhea with curcumin. Dig Dis Sci. 2009;54(10):2188–91.CrossRefPubMedGoogle Scholar
  12. 12.
    Blanco F, San Román J, Vispo E, et al. Management of metabolic complications and cardiovascular risk in HIV-infected patients. AIDS Rev. 2010;12(4):231–41.PubMedGoogle Scholar
  13. 13.
    Catassi C, Bai JC, Bonaz B, et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients. 2013;5(10):3839–53.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Gil L, Lewis L, Martinez G, et al. Effect of increase of dietary micronutrient intake on oxidative stress indicators in HIV/AIDS patients. Int J Vitam Nutr Res. 2005;75(1):19–27.CrossRefPubMedGoogle Scholar
  15. 15.
    Viguiliouk E, Kendall CW, Blanco Mejia S, et al. Effect of tree nuts on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled dietary trials. PLoS ONE. 2014;9(7):e103376.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Bao Y, Han J, Hu FB, et al. Association of nut consumption with total and cause-specific mortality. N Engl J Med. 2013;369:2001–11.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Floch MH, Walker WA, Madsen K, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011;45(Suppl):S168–71.Google Scholar
  18. 18.
    Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11)1728–38.CrossRefPubMedGoogle Scholar
  19. 19.
    Hummelen R, Vos AP, van’t Land B, et al. Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int Rev Immunol. 2010;29:485–513.CrossRefPubMedGoogle Scholar
  20. 20.
    González-Hernández LA, Jave-Suarez LF, Fafutis-Morris M, et al. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutr J. 2012;11:90.Google Scholar
  21. 21.
    MacArthur RD, Levine SD, Birk TJ. Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc. 1993;25(6):684–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59.CrossRefPubMedGoogle Scholar
  23. 23.
    Hand GA, Lyerly GW, Jaggers JR, Dudgeon WD. Impact of aerobic and resistance exercise on the health of HIV-infected persons. Am J Lifestyle Med. 2009;3(6):489–99.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Segatto AF, Freitas IF Jr, Dos Santos, VR, Alves KC, Barbosa DA, Filho AM, Monteiro HL. Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy. Rev Soc Bras Med Trop. 2011;44(4):420–4.Google Scholar
  25. 25.
    Mendes EL, Andaki AC, Brito CJ, Cordova C, Natali AJ, Santos Amorim PR, de Oliveira LL, de Paula SO, Multimura E. Beneficial effects of physical activity in an HIV-infected woman with lipodystrophy: a case report. J Med Case Rep. 2011;5:430.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ullum H, Palmo J, Halkjaer-Kristensen J. The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons. J Acquir Immune Defic Syndr. 1994;7:1122–33.PubMedGoogle Scholar
  27. 27.
    Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6–63.PubMedGoogle Scholar
  28. 28.
    Yahiaoui A, McGough EL, Voss JG. Development of evidence-based exercise recommendations for older HIV-infected patients. J Assoc Nurses AIDS Care. 2012 23(3):204–19.CrossRefPubMedGoogle Scholar
  29. 29.
    Engelson ES, Agin D, Sonjia K, et al. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese HIV-infected women. Metabolism. 2006;55(10):1327–36.CrossRefPubMedGoogle Scholar
  30. 30.
    Gandhi V, Lawrence N. It takes HEART: a multi-faceted weight loss program for people living with HIV. Global Adv Health Med. 2013;2(Suppl):1–3.Google Scholar
  31. 31.
    Kim JH, Gandhi V, Psevdos G Jr, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses. 2012;28(3):235–41.CrossRefPubMedGoogle Scholar
  32. 32.
    Herzlich BC, Schiano TD, Moussa Z, et al. Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. Am J Gastroenterol. 1992;87(12):1781–8.PubMedGoogle Scholar
  33. 33.
    Dolton MJ, Roufogalis BD, McLachlan AJ. Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides. Clin Pharmacol Ther. 2012;92(5):622–30.CrossRefPubMedGoogle Scholar
  34. 34.
    Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol. 2002;54(4):349–56.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18:450.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004:130:601–630.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Thornton LM, Andersen BL. Psychoneuroimmunology examined: the role of subjective stress. Cellscience. 2006:2:66–91.Google Scholar
  38. 38.
    Ironson G, Stuetzle R, Fletcher MA. An increase in religiousness/spirituality occurs after HIV diagnosis and predicts slower disease progression over 4 years in people with HIV. J Gen Intern Med. 2006;21:S62–8.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Rivkin ID, Gustafson J, Weingarten I, et al. The effects of expressive writing on adjustment to HIV. AIDS Behav. 2006;10:13–26.CrossRefPubMedGoogle Scholar
  40. 40.
    Shor-Posner G, Miguez MJ, Hernandez-Reif M, et al. Massage treatment in HIV-1 infected Dominican children: A preliminary report on the massage therapy to preserve the immune system in children without antiretroviral medication. J Altern Complement Med. 2004;10:1093–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Chhatre S, Metzger DS, Frank I, et al. Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV. AIDS Care. 2013;25(10):1291–7.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Phillips KD, Skelton WD, Hand GA. Effect of acupuncture administered in a group setting on pain and subjective peripheral neuropathy in persons with human immunodeficiency virus disease. J Altern Complement Med. 2004;10:449–55.CrossRefPubMedGoogle Scholar
  43. 43.
    Koester KA, Maiorana A, Morin SF, et al. People living with HIV are receptive to HIV prevention interventions in clinical settings: a qualitative evaluation. AIDS Educ Prev. 2012;24(4):295–308.CrossRefPubMedGoogle Scholar
  44. 44.
    Varghese B, Maher JE, Peterman TA, et al. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29(1):38–43.CrossRefPubMedGoogle Scholar
  45. 45.
    Conant M, Hardy D, Sernatinger J, et al. Condoms prevent transmission of AIDS-associated retrovirus. JAMA. 1986;255(13):1706.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Spencer Cox Center for Health, Institute for Advanced Medicine, Mount Sinai St. Luke’s and Mount Sinai Roosevelt HospitalsIcahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Department of MedicineMount Sinai St. Luke’s and Mount Sinai Roosevelt HospitalsNew YorkUSA

Personalised recommendations